WO2025196175 - ORAL CARE COMPOSITIONS COMPRISING DNASES
National phase entry is expected:
Publication Number
WO/2025/196175
Publication Date
25.09.2025
International Application No.
PCT/EP2025/057612
International Filing Date
20.03.2025
Title **
[English]
ORAL CARE COMPOSITIONS COMPRISING DNASES
[French]
COMPOSITIONS DE SOINS BUCCO-DENTAIRES COMPRENANT DES DNASES
Applicants **
NOVOZYMES A/S
Inventors
TIWARI, Manish, Kumar
PALMÉN, Lorena, González
SEGURA, Dorotea, Raventos
HOFF, Tine
Priority Data
24165674.3
22.03.2024
EP
24204207.5
02.10.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2481 | |
| EPO | Filing, Examination, Granting | 9959 | |
| Japan | Filing, Examination, Granting | 2166 | |
| South Korea | Filing, Examination, Granting | 2006 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
23,752
Contact Us
Abstract[English]
The present invention relates to an oral care composition comprising a DNase, use of said composition, use of said composition in treatment of oral disease, methods of treatment comprising administering said composition to a human subject, methods of preventing or removing oral biofilm comprising contacting an oral biofilm with said composition, methods for reducing the risk of oral biofilm formation, and kits of parts comprising said composition.[French]
La présente invention concerne une composition de soins buccodentiares comprenant une DNase, l'utilisation de ladite composition, l'utilisation de ladite composition dans le traitement d'une maladie buccale, des méthodes de traitement comprenant l'administration de ladite composition à un sujet humain, des méthodes de prévention ou d'élimination de biofilm buccal comprenant la mise en contact d'un biofilm buccal avec ladite composition, des méthodes de réduction du risque de formation de biofilm buccal, et des kits comprenant ladite composition.